John Wiley & Sons (NYSE:WLY – Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.47 earnings per share for the quarter, missing the consensus estimate of $0.55 by ($0.08), Briefing.com reports. John Wiley & Sons had a positive return on equity of 18.82% and a negative net margin of 10.69%. The business had revenue of $403.81 million during the quarter, compared to analysts’ expectations of $387.40 million. During the same quarter in the prior year, the firm earned $0.27 EPS. The firm’s revenue for the quarter was down 10.5% compared to the same quarter last year. John Wiley & Sons updated its FY25 guidance to $3.25-3.60 EPS and its FY 2025 guidance to 3.250-3.600 EPS.
John Wiley & Sons Stock Down 3.2 %
WLY opened at $43.21 on Friday. The stock has a market capitalization of $2.35 billion, a price-to-earnings ratio of -11.87 and a beta of 0.86. The firm has a 50 day moving average price of $45.81 and a 200-day moving average price of $40.24. John Wiley & Sons has a twelve month low of $28.83 and a twelve month high of $49.20. The company has a quick ratio of 0.49, a current ratio of 0.52 and a debt-to-equity ratio of 1.04.
John Wiley & Sons Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, July 25th. Stockholders of record on Tuesday, July 9th were issued a dividend of $0.3525 per share. This represents a $1.41 dividend on an annualized basis and a dividend yield of 3.26%. The ex-dividend date of this dividend was Tuesday, July 9th. This is an increase from John Wiley & Sons’s previous quarterly dividend of $0.35. John Wiley & Sons’s dividend payout ratio (DPR) is presently -38.74%.
John Wiley & Sons Company Profile
John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.
See Also
- Five stocks we like better than John Wiley & Sons
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- Profitably Trade Stocks at 52-Week Highs
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- Bank Stocks – Best Bank Stocks to Invest In
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for John Wiley & Sons Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John Wiley & Sons and related companies with MarketBeat.com's FREE daily email newsletter.